PHARMACOGENOMICS JOURNAL

Literals

• ou:categoriaSJR
  • Pharmacology (Q1)
  • Molecular Medicine (Q2)
  • Genetics (Q2)
• vcard:country-name
  • United Kingdom
• ou:codigoRevista
  • 1473-1150
  • 1470-269X
• dcterms:coverage
  • 2001-2020
• bibo:eissn
  • 1473-1150
• dcterms:identifier
  • 2016-10318
• bibo:issn
  • 1470-269X
• dcterms:publisher
  • Nature Publishing Group
• vcard:region
  • Western Europe
• ou:sjrMejorCuartil
  • Q1
• dcterms:title
  • PHARMACOGENOMICS JOURNAL

Typed Literals

• ou:sjr
  • 1.377 (http://www.w3.org/2001/XMLSchema#Decimal)

Inverse Relations

• Has related: ou:publicadaEnRevista
  • CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy
  • High frequency of CYP2D6 ultrarapid metabolizers in Spain: Controversy about their misclassification in worldwide population studies
  • Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations
  • Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: Role of dopamine, serotonin and glutamate candidate genes